These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 9864931)

  • 1. Blastogenic response of activated human umbilical cord blood T-lymphocytes.
    D'Arena G; Cascavilla N; Carotenuto M
    Haematologica; 1998 Nov; 83(11):1048-50. PubMed ID: 9864931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flow cytometric characterization of human umbilical cord blood lymphocytes: immunophenotypic features.
    D'Arena G; Musto P; Cascavilla N; Di Giorgio G; Fusilli S; Zendoli F; Carotenuto M
    Haematologica; 1998 Mar; 83(3):197-203. PubMed ID: 9573672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Umbilical cord blood-naive T cells but not adult blood-naive T cells require HLA class II on antigen-presenting cells for allo-immune activation.
    Kloosterboer FM; van Luxemburg-Heijs SA; Willemze R; Falkenburg JH
    Hum Immunol; 2004 Apr; 65(4):328-39. PubMed ID: 15120187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotypic and functional analysis of peripheral blood mononuclear cells in generalised aggressive and chronic periodontitis patients.
    Emingil G; Karaarslan F; Keskinoğlu A; Coker I; Atilla G
    J Int Acad Periodontol; 2001 Oct; 3(4):87-94. PubMed ID: 12666947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Study on the immunologic function of lymphocyte in cord blood].
    Zhu H; Sun Z; Dai H
    Zhonghua Xue Ye Xue Za Zhi; 2001 Aug; 22(8):423-5. PubMed ID: 11718094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased frequency of CD3/8/56-positive umbilical cord blood T lymphocytes after allo-priming in vitro.
    Hagihara M; Chargui J; Gansuvd B; Inoue H; Hotta T; Kato S
    Ann Hematol; 2003 Mar; 82(3):166-70. PubMed ID: 12634949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation-associated phenotype of CD3 T cells in acute graft-versus-host disease.
    Paz Morante M; Briones J; Canto E; Sabzevari H; Martino R; Sierra J; Rodriguez-Sanchez JL; Vidal S
    Clin Exp Immunol; 2006 Jul; 145(1):36-43. PubMed ID: 16792671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different roles of IL-15 from IL-2 in differentiation and activation of human CD3+CD56+ NKT-like cells from cord blood in long term culture.
    Wang Y; Zheng X; Wei H; Sun R; Tian Z
    Int Immunopharmacol; 2008 Jun; 8(6):927-34. PubMed ID: 18442800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The functional immaturity of dendritic cells can be relevant to increased tolerance associated with cord blood transplantation.
    Encabo A; Solves P; Carbonell-Uberos F; Miñana MD
    Transfusion; 2007 Feb; 47(2):272-9. PubMed ID: 17302774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired allogeneic activation and T-helper 1 differentiation of human cord blood naive CD4 T cells.
    Chen L; Cohen AC; Lewis DB
    Biol Blood Marrow Transplant; 2006 Feb; 12(2):160-71. PubMed ID: 16443514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrophage colony stimulating factor (M-CSF) within cord blood sera may be partially responsible for the reduced proliferation of cord blood T cells.
    Cohen SB; Woolley J; Bogunia-Kubik K; Natarajan P; Kotecha R; Belaramani L; Fallen PR; Perez-Cruz I; Madrigal JA
    Eur Cytokine Netw; 2000 Dec; 11(4):608-17. PubMed ID: 11125304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discrepancy in expression ability of Tac antigen and Ia determinants defined by monoclonal antibodies on activated or cultured cord blood T lymphocytes.
    Yokoi T; Miyawaki T; Yachie A; Ohzeki S; Taniguchi N
    J Immunol; 1982 Oct; 129(4):1441-5. PubMed ID: 6980936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Photochemical treatment with S-59 psoralen and ultraviolet A light to control the fate of naive or primed T lymphocytes in vivo after allogeneic bone marrow transplantation.
    Truitt RL; Johnson BD; Hanke C; Talib S; Hearst JE
    J Immunol; 1999 Nov; 163(9):5145-56. PubMed ID: 10528221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential cyclosporin-A sensitivity on survival and activation of umbilical cord and adult peripheral blood CD4+ T cells.
    Lin SJ; Kuo ML; Cheng PJ; Hsiao SS
    Transpl Immunol; 2007 Nov; 18(2):172-8. PubMed ID: 18005864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinctive response of naïve lymphocytes from cord blood to primary activation via TCR.
    Cantó E; Rodriguez-Sanchez JL; Vidal S
    J Leukoc Biol; 2003 Dec; 74(6):998-1007. PubMed ID: 12972509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Umbilical cord blood T lymphocytes are induced to apoptosis after being allo-primed in vitro.
    Hagihara M; Chargui J; Gansuvd B; Tsuchida F; Sato T; Hotta T; Kato S
    Bone Marrow Transplant; 1999 Dec; 24(11):1229-33. PubMed ID: 10642813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ex vivo expanded umbilical cord blood T cells maintain naive phenotype and TCR diversity.
    Parmar S; Robinson SN; Komanduri K; St John L; Decker W; Xing D; Yang H; McMannis J; Champlin R; de Lima M; Molldrem J; Rieber A; Bonyhadi M; Berenson R; Shpall EJ
    Cytotherapy; 2006; 8(2):149-57. PubMed ID: 16698688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inefficient phospholipase C activation and reduced Lck expression characterize the signaling defect of umbilical cord T lymphocytes.
    Miscia S; Di Baldassarre A; Sabatino G; Bonvini E; Rana RA; Vitale M; Di Valerio V; Manzoli FA
    J Immunol; 1999 Sep; 163(5):2416-24. PubMed ID: 10452976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Susceptibility to Fas and tumor necrosis factor-alpha receptor mediated apoptosis of anti-CD3/anti-CD28-activated umbilical cord blood T cells.
    Lin SJ; Lee CC; Cheng PJ; See LC; Kuo ML
    Pediatr Allergy Immunol; 2009 Jun; 20(4):392-8. PubMed ID: 18713315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hematopoietic stem cell graft manipulation as a mechanism of immunotherapy.
    Talmadge JE
    Int Immunopharmacol; 2003 Aug; 3(8):1121-43. PubMed ID: 12860168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.